The FDA-approved smoking cessation pill, varenicline, has emerged as a game-changer in the fight against nicotine addiction, particularly for young people grappling with vaping.Recent clinical trials revealed that teens and young adults taking this twice-daily medication were over three times more likely to quit vaping successfully than those receiving just behavioral counseling.